Compare Stocks → The World's First '$20 Trillion Drug?' (From Behind the Markets) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:DOCNYSE:EPRNYSE:EQCNASDAQ:PCHNASDAQ:SBRA Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDOCHealthpeak Properties$18.34-1.6%$16.52$15.24▼$22.38$13.01B1.027.27 million shs6.98 million shsEPREPR Properties$41.13-0.1%$41.60$39.01▼$49.10$3.11B1.65649,106 shs650,042 shsEQCEquity Commonwealth$18.61-0.3%$18.71$17.93▼$21.49$1.99B0.24912,088 shs1.08 million shsPCHPotlatchDeltic$41.04-0.9%$44.77$40.47▼$54.44$3.26B1.15415,878 shs535,221 shsSBRASabra Health Care REIT$13.65-0.4%$14.06$10.30▼$14.91$3.16B1.162.04 million shs1.87 million shs12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDOCHealthpeak Properties+1.00%+3.13%+6.27%+45.13%+31.70%EPREPR Properties+0.05%+2.82%-0.44%-7.71%+1.01%EQCEquity Commonwealth+0.27%+0.65%-0.67%-2.51%-8.80%PCHPotlatchDeltic-0.10%+0.58%-10.37%-10.70%-11.14%SBRASabra Health Care REIT-0.58%+1.78%-5.19%+3.63%+25.80%The Gold Grab of the Century (Ad)When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDOCHealthpeak Properties3.5188 of 5 stars1.33.02.53.71.91.71.9EPREPR Properties3.8767 of 5 stars2.13.02.52.12.61.71.9EQCEquity Commonwealth1.7908 of 5 stars0.03.00.00.02.92.51.9PCHPotlatchDeltic3.9341 of 5 stars2.03.01.70.93.22.52.5SBRASabra Health Care REIT2.3207 of 5 stars2.34.01.70.03.31.70.6Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDOCHealthpeak Properties2.50Moderate Buy$18.10-1.31% DownsideEPREPR Properties2.20Hold$48.0516.84% UpsideEQCEquity CommonwealthN/AN/AN/AN/APCHPotlatchDeltic2.00Hold$51.3325.08% UpsideSBRASabra Health Care REIT2.60Moderate Buy$15.7715.55% UpsideCurrent Analyst RatingsLatest SBRA, DOC, EQC, PCH, and EPR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/22/2024DOCHealthpeak PropertiesMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy$22.004/10/2024DOCHealthpeak PropertiesRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$21.00 ➝ $22.004/1/2024DOCHealthpeak PropertiesBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeUnderperform ➝ Buy$18.00 ➝ $25.003/25/2024DOCHealthpeak PropertiesWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageEqual Weight$19.003/22/2024EPREPR PropertiesTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$51.00 ➝ $46.003/8/2024DOCHealthpeak PropertiesRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform$21.002/29/2024SBRASabra Health Care REITWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform$17.001/31/2024PCHPotlatchDelticTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$51.00 ➝ $49.001/31/2024PCHPotlatchDelticRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSector Perform ➝ Sector Perform$48.001/30/2024SBRASabra Health Care REITDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$21.00(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDOCHealthpeak Properties$2.18B5.97$1.74 per share10.55$12.57 per share1.46EPREPR Properties$705.67M4.41$4.64 per share8.87$32.58 per share1.26EQCEquity Commonwealth$60.52M32.89$1.02 per share18.27$21.28 per share0.87PCHPotlatchDeltic$1.02B3.19$1.93 per share21.22$27.17 per share1.51SBRASabra Health Care REIT$647.51M4.88$0.84 per share16.19$12.12 per share1.13Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDOCHealthpeak Properties$306.01M$0.5632.759.811.8213.97%4.34%1.95%4/25/2024 (Confirmed)EPREPR Properties$173.05M$1.9720.888.48N/A24.52%6.96%3.03%5/1/2024 (Confirmed)EQCEquity Commonwealth$91.16M$0.7624.48∞N/A150.62%4.04%3.78%5/1/2024 (Confirmed)PCHPotlatchDeltic$62.10M$0.7753.3048.86N/A6.06%1.58%1.00%4/29/2024 (Confirmed)SBRASabra Health Care REIT$13.76M$0.05273.009.484.952.12%0.47%0.25%5/8/2024 (Confirmed)Latest SBRA, DOC, EQC, PCH, and EPR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2024N/ASBRASabra Health Care REIT$0.33N/A-$0.33N/AN/AN/A 5/1/2024N/AEPREPR Properties$1.12N/A-$1.12N/AN/AN/A 5/1/2024N/AEQCEquity CommonwealthN/AN/AN/AN/AN/AN/A 4/29/2024N/APCHPotlatchDeltic-$0.0130N/A+$0.0130N/AN/AN/A 4/25/2024N/ADOCHealthpeak Properties$0.44$0.45+$0.01N/A$589.28 million$606.50 million DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDOCHealthpeak Properties$1.206.54%N/A214.29%N/AEPREPR Properties$3.428.32%+29.63%173.60%1 YearsEQCEquity CommonwealthN/AN/AN/AN/AN/APCHPotlatchDeltic$1.804.39%+3.79%233.77%N/ASBRASabra Health Care REIT$1.208.79%-3.85%2,400.00%N/ALatest SBRA, DOC, EQC, PCH, and EPR DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/15/2024EPREPR PropertiesMonthly$0.28508.6%4/29/20244/30/20245/15/20242/28/2024EPREPR Propertiesmonthly$0.28508.3%3/27/20243/28/20244/15/20242/9/2024PCHPotlatchDelticquarterly$0.454.03%3/7/20243/8/20243/29/20242/9/2024PCHPotlatchDelticquarterly$0.454.03%3/8/20243/29/20242/15/2024EPREPR Propertiesmonthly$0.27507.8%2/28/20242/29/20243/15/20242/1/2024SBRASabra Health Care REITQuarterly$0.309.18%2/12/20242/13/20242/29/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDOCHealthpeak Properties1.000.670.67EPREPR Properties1.157.537.53EQCEquity CommonwealthN/A79.7279.72PCHPotlatchDeltic0.401.441.14SBRASabra Health Care REIT0.863.413.41OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDOCHealthpeak Properties93.57%EPREPR Properties74.66%EQCEquity Commonwealth96.00%PCHPotlatchDeltic86.06%SBRASabra Health Care REIT99.40%Insider OwnershipCompanyInsider OwnershipDOCHealthpeak Properties0.30%EPREPR Properties1.89%EQCEquity Commonwealth2.80%PCHPotlatchDeltic2.00%SBRASabra Health Care REIT1.00%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableDOCHealthpeak Properties193709.58 million707.45 millionOptionableEPREPR Properties5575.67 million74.24 millionOptionableEQCEquity Commonwealth22106.99 million104.00 millionOptionablePCHPotlatchDeltic1,38479.51 million77.92 millionOptionableSBRASabra Health Care REIT48231.48 million229.16 millionOptionableSBRA, DOC, EQC, PCH, and EPR HeadlinesSourceHeadlineSabra Health Care REIT, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Callbusinesswire.com - April 24 at 4:05 PMSumitomo Mitsui Trust Holdings Inc. Reduces Stock Holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)marketbeat.com - April 23 at 4:51 AMGraniteShares Advisors LLC Invests $1.46 Million in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)marketbeat.com - April 16 at 7:23 PMWill This REIT Portfolio – up to 9.3% – Finally Get Off the Ground?marketbeat.com - April 15 at 10:05 PMSabra Health Care REIT, Inc. (NASDAQ:SBRA) Given Average Recommendation of "Moderate Buy" by Analystsmarketbeat.com - April 8 at 2:32 AMTruist Financial Keeps Their Buy Rating on Sabra Healthcare REIT (SBRA)markets.businessinsider.com - April 6 at 10:28 AMLDR Capital Management LLC Sells 72,931 Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA)marketbeat.com - April 5 at 11:48 PMMedical Properties Trust Q4: Wouldn't Touch This REIT With A 10-Foot Poleseekingalpha.com - April 4 at 6:31 PMSabra Health Care REIT (NASDAQ:SBRA) Hits New 1-Year High at $14.91marketbeat.com - March 28 at 4:34 PMSabra Health Care REIT, Inc. to Attend the Deutsche Bank Inaugural Healthcare REIT Summitbusinesswire.com - March 19 at 4:05 PMHealthcare havens: The medical REIT with a pulse on the futurefinbold.com - March 15 at 11:12 AM6 Bargain Dividend Stocks To Buy247wallst.com - March 8 at 2:09 PMAnalysts’ Opinions Are Mixed on These Real Estate Stocks: Sabra Healthcare REIT (SBRA) and RLJ Lodging (RLJ)markets.businessinsider.com - March 3 at 5:54 PMSabra Health Care REIT, Inc. (NASDAQ:SBRA) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 3 at 12:53 PMSabra Health Care REIT, Inc. (SBRA) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 1 at 2:06 PMAnalysts Offer Insights on Real Estate Companies: Summit Hotel Properties (INN) and Sabra Healthcare REIT (SBRA)markets.businessinsider.com - March 1 at 9:06 AMQ4 2023 Sabra Health Care REIT Inc Earnings Callfinance.yahoo.com - February 29 at 9:49 AMSabra (SBRA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimateszacks.com - February 27 at 8:01 PMSabra Healthcare (SBRA) Lags Q4 FFO and Revenue Estimateszacks.com - February 27 at 7:21 PMSabra Reports Fourth Quarter 2023 Results; Introduces 2024 Guidancefinance.yahoo.com - February 27 at 5:18 PMSabra Health Care REIT Inc (SBRA) Reports Q4 2023 Earnings and Introduces 2024 Guidancefinance.yahoo.com - February 27 at 5:18 PMSabra Reports Fourth Quarter 2023 Results; Introduces 2024 Guidancebusinesswire.com - February 27 at 4:05 PMHere's what Wall Street expects from Sabra Health Care REIT's earnings reportmarkets.businessinsider.com - February 26 at 4:14 PMSabra Health Care Q4 2023 Earnings Previewmsn.com - February 26 at 4:14 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s PortfolioStock market today: Wall Street falls on double dose of disappointing economic data, as Meta sinksApril 25, 2024 2:14 AMView Stock market today: Wall Street falls on double dose of disappointing economic data, as Meta sinksFoot Locker Builds Up Another Head of Steam; Gains ImminentMarch 28, 2024 10:58 AMView Foot Locker Builds Up Another Head of Steam; Gains Imminent5 Stocks in the Current Bull Market with Upside to ComeApril 5, 2024 10:14 AMView 5 Stocks in the Current Bull Market with Upside to ComeDocuSign and The Case for 66% Upside April 16, 2024 10:20 AMView DocuSign and The Case for 66% Upside All Headlines Company DescriptionsHealthpeak PropertiesNYSE:DOCHealthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.EPR PropertiesNYSE:EPREPR Properties (NYSE:EPR) is the leading diversified experiential net lease real estate investment trust (REIT), specializing in select enduring experiential properties in the real estate industry. We focus on real estate venues that create value by facilitating out of home leisure and recreation experiences where consumers choose to spend their discretionary time and money. We have total assets of approximately $5.7 billion (after accumulated depreciation of approximately $1.4 billion) across 44 states. We adhere to rigorous underwriting and investing criteria centered on key industry, property and tenant level cash flow standards. We believe our focused approach provides a competitive advantage and the potential for stable and attractive returns.Equity CommonwealthNYSE:EQCEquity Commonwealth (NYSE: EQC) is a Chicago based, internally managed and self-advised real estate investment trust (REIT) with commercial office properties in the United States. EQC's portfolio is comprised of four properties totaling 1.5 million square feet.PotlatchDelticNASDAQ:PCHPotlatchDeltic Corporation (Nasdaq: PCH) is a leading Real Estate Investment Trust (REIT) that owns nearly 2.2 million acres of timberlands in Alabama, Arkansas, Georgia, Idaho, Louisiana, Mississippi and South Carolina. Through its taxable REIT subsidiary, the company also operates six sawmills, an industrial-grade plywood mill, a residential and commercial real estate development business and a rural timberland sales program. PotlatchDeltic, a leader in sustainable forest management, is committed to environmental and social responsibility and to responsible governance.Sabra Health Care REITNASDAQ:SBRAAs of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures. As of September 30, 2023, Sabra's real estate properties held for investment included 37,606 beds/units, spread across the United States and Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.